Anthera Pharmaceuticals Inc (ANTH) Financial Statements (2024 and earlier)

Company Profile

Business Address 25801 INDUSTRIAL BOULEVARD, SUITE B
HAYWARD, CA 94545
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

3/31/2018
MRQ
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 2,19620,84346,9512,63925,94624,753
Cash and cash equivalents 2,19620,84346,9512,63925,94619,431
Short-term investments      5,322
Receivables   326   
Prepaid expense and other current assets426
Other undisclosed current assets 9951,865585383358 
Total current assets: 3,19122,70847,8623,02226,30425,179
Noncurrent Assets
Property, plant and equipment 4827632634688121,150
Regulated entity, other noncurrent assets      116
Restricted cash and investments     10,000 
Other noncurrent assets     301
Total noncurrent assets: 48276326346811,1131,266
TOTAL ASSETS: 3,67323,47148,1253,49037,41726,445
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 2,9266,7406,9533,5124,3126,047
Employee-related liabilities 281,8451,5961,069319344
Accounts payable 1,8324,7825,2592,2323,5195,206
Accrued liabilities 1,06611398211474497
Debt     2,7779,329
Other liabilities    1,000  
Deferred revenue and credits   138   
Other undisclosed current liabilities 1,7853,8841,3771,2394723,374
Total current liabilities: 4,71110,6248,4685,7517,56118,750
Noncurrent Liabilities
Long-term debt and lease obligation     15,09811,221
Long-term debt, excluding current maturities     15,09811,221
Liabilities, other than long-term debt 4,457     
Other liabilities 4,457     
Total noncurrent liabilities: 4,457   15,09811,221
Total liabilities: 9,16810,6248,4685,75122,65929,971
Equity
Equity, attributable to parent, including: (5,495)12,47039,657(2,261)14,758(3,526)
Common stock 144640231979
Additional paid in capital 428,586411,364391,648314,527301,946256,790
Accumulated other comprehensive loss      (17)
Accumulated deficit (434,428)(407,554)(352,031)(316,811)  
Other undisclosed equity, attributable to parent 3338,614  (287,207)(260,378)
Other undisclosed equity  377    
Total equity: (5,495)12,84739,657(2,261)14,758(3,526)
TOTAL LIABILITIES AND EQUITY: 3,67323,47148,1253,49037,41726,445

Income Statement (P&L) ($ in thousands)

3/31/2018
TTM
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Revenues
(Revenue, Net)
  1453,185  245
Gross profit:  1453,185  245
Operating expenses (36,432)(57,322)(38,428)(28,459)(28,247)(55,934)
Other undisclosed operating loss      (245)
Operating loss: (36,432)(57,177)(35,243)(28,459)(28,247)(55,934)
Nonoperating income (expense) 9,5581,65423 (2,614)(3,465)
Other nonoperating income (expense) (85)(90)23   
Interest and debt expense    (1,049)(2,599)(3,354)
Loss from continuing operations: (26,874)(55,523)(35,220)(29,508)(33,460)(62,753)
Loss before gain (loss) on sale of properties: (26,874)(55,523)(35,220)(29,508)(33,460)(62,753)
Net loss: (26,874)(55,523)(35,220)(29,508)(33,460)(62,753)
Other undisclosed net income (loss) attributable to parent    (96)2,5993,354
Net loss attributable to parent: (26,874)(55,523)(35,220)(29,604)(30,861)(59,399)
Other undisclosed net loss available to common stockholders, basic (2,503)(10,914)    
Net loss available to common stockholders, diluted: (29,377)(66,437)(35,220)(29,604)(30,861)(59,399)

Comprehensive Income ($ in thousands)

3/31/2018
TTM
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Net loss: (26,874)(55,523)(35,220)(29,508)(33,460)(62,753)
Comprehensive loss: (26,874)(55,523)(35,220)(29,508)(33,460)(62,753)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent    (96)2,6163,366
Comprehensive loss, net of tax, attributable to parent: (26,874)(55,523)(35,220)(29,604)(30,844)(59,387)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: